ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain

Neurobiology of Aging

Volumn 30, Issue 4, 2009, Pages 591-599

  Bandaru, Veera Venkata Ratnam ^a   Troncoso, Juan ^a   Wheeler, David ^a   Pletnikova, Olga ^a   Wang, Jessica ^a   Conant, Kathy ^a   Haughey, Norman J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; ApoE; ApoE4; Apolipoprotein; Ceramide; Cholesterol; Sphingolipid; Sphingomeylin; Sterol

Indexed keywords

4 HYDROXYNONENAL; APOLIPOPROTEIN E4; CERAMIDE; CHOLESTEROL; CHOLESTEROL ESTER; SPHINGOMYELIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DNA POLYMORPHISM; GRAY MATTER; HUMAN; HUMAN TISSUE; LIPID METABOLISM; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEROL METABOLISM; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; BRAIN; BRAIN CHEMISTRY; CERAMIDES; CHOLESTEROL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NEUROCHEMISTRY; SPHINGOLIPIDS; STEROLS;

EID: 61649120841     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.07.024     Document Type: Article

References (45)

1. Abad-Rodriguez J., Ledesma M.D., Craessaerts K., Perga S., Medina M., Delacourte A., Dingwall C., De Strooper B., and Dotti C.G. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J. Cell. Biol. 167 (2004) 953-960
2. Bodovitz S., and Klein W.L. Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 271 (1996) 4436-4440
3. Bohnet K., Pillot T., Visvikis S., Sabolovic N., and Siest G. Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors. J. Lipid Res. 37 (1996) 1316-1324
4. Brann A.B., Scott R., Neuberger Y., Abulafia D., Boldin S., Fainzilber M., and Futerman A.H. Ceramide signaling downstream of the p75 neurotrophin receptor mediates the effects of nerve growth factor on outgrowth of cultured hippocampal neurons. J. Neurosci. 19 (1999) 8199-8206
5. Brown C.M., Wright E., Colton C.A., Sullivan P.M., Laskowitz D.T., and Vitek M.P. Apolipoprotein E isoform mediated regulation of nitric oxide release. Free Radic. Biol. Med. 32 (2002) 1071-1075
6. Castiglione M., Spinsanti P., Iacovelli L., Lenti L., Martini F., Gradini R., Di Giorgi Gerevini V., Caricasole A., Caruso A., De Maria R., Nicoletti F., and Melchiorri D. Activation of Fas receptor is required for the increased formation of the disialoganglioside GD3 in cultured cerebellar granule cells committed to apoptotic death. Neuroscience 126 (2004) 889-898
7. Colton C.A., Brown C.M., Czapiga M., and Vitek M.P. Apolipoprotein-E allele-specific regulation of nitric oxide production. Ann. N.Y. Acad. Sci. 962 (2002) 212-225
8. Cordy J.M., Hussain I., Dingwall C., Hooper N.M., and Turner A.J. Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 11735-11740
9. Cutler R.G., Kelly J., Storie K., Pedersen W.A., Tammara A., Hatanpaa K., Troncoso J.C., and Mattson M.P. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 2070-2075
10. Cutler R.G., Haughey N.J., Tammara A., McArthur J.C., Nath A., Reid R., Vargas D.L., Pardo C.A., and Mattson M.P. Dysregulation of sphingolipid and sterol metabolism by ApoE4 in HIV dementia. Neurology 63 (2004) 626-630
11. Dong L.M., Wilson C., Wardell M.R., Simmons T., Mahley R.W., Weisgraber K.H., and Agard D.A. Human apolipoprotein E, Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J. Biol. Chem. 269 (1994) 22358-22365
12. Ehehalt R., Keller P., Haass C., Thiele C., and Simons K. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell. Biol. 160 (2003) 113-123
13. Fagan A.M., Bu G., Sun Y., Daugherty A., and Holtzman D.M. Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J. Biol. Chem. 271 (1996) 30121-30125
14. Gregg R.E., Zech L.A., Schaefer E.J., Stark D., Wilson D., and Brewer Jr. H.B. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J. Clin. Invest. 78 (1986) 815-821
15. Guillaume D., Bertrand P., Dea D., Davignon J., and Poirier J. Apolipoprotein E and low-density lipoprotein binding and internalization in primary cultures of rat astrocytes: isoform-specific alterations. J. Neurochem. 66 (1996) 2410-2418
16. Han X.D.M.H., McKeel Jr. D.W., Kelley J., and Morris J.C. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J. Neurochem. 82 (2002) 809-818
17. Haughey N.J., Cutler R.G., Tamara A., McArthur J.C., Vargas D.L., Pardo C.A., Turchan J., Nath A., and Mattson M.P. Involvement of perturbed sphingolipid metabolism and ceramide production in the pathogenesis of HIV dementia. Ann. Neurol. 55 (2003) 257-267
18. Haughey N.J., Cutler R.G., Tamara A., McArthur J.C., Vargas D.L., Pardo C.A., Turchan J., Nath A., and Mattson M.P. Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia. Ann. Neurol. 55 (2004) 257-267
19. Heeren J., Grewal T., Laatsch A., Becker N., Rinninger F., Rye K.A., and Beisiegel U. Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation. J. Biol. Chem. 279 (2004) 55483-55492
20. Hixson J.E., and Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31 (1990) 545-548
21. Huang Y., von Eckardstein A., Wu S., and Assmann G. Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma. J. Clin. Invest. 96 (1995) 2693-2701
22. Ignatius M.J., Shooter E.M., Pitas R.E., and Mahley R.W. Lipoprotein uptake by neuronal growth cones in vitro. Science 236 (1987) 959-962
23. Knouff C., Hinsdale M.E., Mezdour H., Altenburg M.K., Watanabe M., Quarfordt S.H., Sullivan P.M., and Maeda N. Apo E structure determines VLDL clearance and atherosclerosis risk in mice. J. Clin. Invest. 103 (1999) 1579-1586
24. Kojro E., Gimpl G., Lammich S., Marz W., and Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 5815-5820
25. Lee J.T., Xu J., Lee J.M., Ku G., Han X., Yang D.I., Chen S., and Hsu C.Y. Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J. Cell. Biol. 164 (2004) 123-131
26. Lehtovirta M., Soininen H., Laakso M.P., Partanen K., Helisalmi S., Mannermaa A., Ryynanen M., Kuikka J., Hartikainen P., and Riekkinen Sr. P.J. SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele. J. Neurol. Neurosurg. Psychiatry 60 (1996) 644-649
27. Levi O., Jongen-Relo A.L., Feldon J., Roses A.D., and Michaelson D.M. ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory. Neurobiol. Dis. 13 (2003) 273-282
28. Love S., Siew L.K., Dawbarn D., Wilcock G.K., Ben-Shlomo Y., and Allen S.J. Premorbid effects of APOE on synaptic proteins in human temporal neocortex. Neurobiol. Aging (2005)
29. Lutjohann D., Papassotiropoulos A., Bjorkhem I., Locatelli S., Bagli M., Oehring R.D., Schlegel U., Jessen F., Rao M.L., von Bergmann K., and Heun R. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J. Lipid Res. 41 (2000) 195-198
30. Mauch D.H., Nagler K., Schumacher S., Goritz C., Muller E.C., Otto A., and Pfrieger F.W. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294 (2001) 1354-1357
31. Michikawa M., Fan Q.W., Isobe I., and Yanagisawa K. Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J. Neurochem. 74 (2000) 1008-1016
32. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., and Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 (1991) 479-486
33. Mulder M., Ravid R., Swaab D.F., de Kloet E.R., Haasdijk E.D., Julk J., van der Boom J.J., and Havekes L.M. Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4. Alzheimer Dis. Assoc. Disord. 12 (1998) 198-203
34. Narita M., Bu G., Holtzman D.M., and Schwartz A.L. The low-density lipoprotein receptor-related protein, a multifunctional apolipoprotein E receptor, modulates hippocampal neurite development. J. Neurochem. 68 (1997) 587-595
35. Nathan B.P., Bellosta S., Sanan D.A., Weisgraber K.H., Mahley R.W., and Pitas R.E. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264 (1994) 850-852
36. Nathan B.P., Jiang Y., Wong G.K., Shen F., Brewer G.J., and Struble R.G. Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein. Brain Res. 928 (2002) 96-105
37. Papassotiropoulos A., Lutjohann D., Bagli M., Locatelli S., Jessen F., Buschfort R., Ptok U., Bjorkhem I., von Bergmann K., and Heun R. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J. Psychiatr. Res. 36 (2002) 27-32
38. Perugini M.A., Schuck P., and Howlett G.J. Differences in the binding capacity of human apolipoprotein E3 and E4 to size-fractionated lipid emulsions. Eur. J. Biochem. 269 (2002) 5939-5949
39. Riddell D.R., Christie G., Hussain I., and Dingwall C. Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts. Curr. Biol. 11 (2001) 1288-1293
40. Sanchez-Alavez M., Tabarean I.V., Behrens M.M., and Bartfai T. Ceramide mediates the rapid phase of febrile response to IL-1beta. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 2904-2908
41. Sortino M.A., Condorelli F., Vancheri C., and Canonico P.L. Tumor necrosis factor-alpha induces apoptosis in immortalized hypothalamic neurons: involvement of ceramide-generating pathways. Endocrinology 140 (1999) 4841-4849
42. Trommsdorff M., Gotthardt M., Hiesberger T., Shelton J., Stockinger W., Nimpf J., Hammer R.E., Richardson J.A., and Herz J. Reeler/disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97 (1999) 689-701
43. Veinbergs I., Van Uden E., Mallory M., Alford M., McGiffert C., DeTeresa R., Orlando R., and Masliah E. Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E. Exp. Neurol. 170 (2001) 15-26
44. Wahrle S., Das P., Nyborg A.C., McLendon C., Shoji M., Kawarabayashi T., Younkin L.H., Younkin S.G., and Golde T.E. Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol. Dis. 9 (2002) 11-23
45. Weisgraber K.H. Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. J. Lipid Res. 31 (1990) 1503-1511